Search Results

You are looking at 1 - 3 of 3 items for

  • Author or Editor: Jeffrey Silberzweig x
  • Refine by Content Type: All x
Clear All Modify Search
Jeffrey Silberzweig

In a JASN study, Garcia and colleagues (1) report a survey of patients treated by hemodialysis at 150 facilities in the United States (Figure 1). The 1515 respondents represented 14% of eligible patients. Vaccine hesitancy was reported by 20% with a distribution similar to that of the general population: it was more common among women, people of Black race, Native Americans and Pacific Islanders, as well as younger patients. The most frequently stated reason for vaccine hesitancy was concern about side effects. The most trusted source of information about vaccines was dialysis facility staff,

Jeffrey Silberzweig, Alan S. Kliger, and Susan Stark

The COVID-19 pandemic has been devastating for kidney patients and challenging for nephrologists, nurses, and other caregivers. However, in the kidney community, it has led to collaborations that reduced the impact of COVID-19—collaborations that promise to serve kidney patients and professionals long into the future.

In March 2020, ASN formed the COVID-19 Response Team as a forum to gather accurate, unbiased information from reliable sources and to share it broadly with the kidney community, nationally, and regionally. The pandemic's ever-changing realities required continuous refinement, underscored the need to learn from one another's experience, and offered the opportunity to build on

Thomas H. Watson, Daniel E. Weiner, Jerry Yee, Jeffrey Silberzweig, and for the Outpatient Dialysis Subcommittee of the American Society of Nephrology COVID-19 Response Team

Nearly 800,000 patients in the United States have end-stage kidney disease, with more than 550,000 receiving maintenance dialysis (1). Compared to the general population, dialysis patients incur a greater burden of illness, with more comorbid conditions, including diabetes mellitus, hypertension, intrinsic pulmonary disease, cardiovascular and cerebrovascular disease, obesity, and frailty. Individuals dependent on maintenance dialysis are extremely vulnerable to the effects of infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), with COVID-associated mortality likely exceeding 20% (2).

In October 2020, the National Academy of Medicine released its